# Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation

> **NCT04918953** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 90 (estimated)

## Conditions studied

- Outcome

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** budesonide atomization suspension

## Key facts

- **NCT ID:** NCT04918953
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-06-02
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918953, "Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04918953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
